Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 12, 2021
Jan. 06, 2021
May 15, 2020
Jul. 16, 2021
Jun. 25, 2021
Jun. 18, 2021
Feb. 18, 2021
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Jun. 30, 2021
May 31, 2021
Dec. 31, 2020
Stockholders' Equity (Details) [Line Items]                              
Issued of common stock (in Shares)               17,501,554       17,501,554     16,332,939
Exercise of options for proceeds (in Dollars)               $ 52,156 $ 105,875 $ 457,623 $ 73,020        
Granting to option or stock awards (in Shares)               6,652,942       6,652,942   1,500,000  
Stock options exercisable Period                       10 years      
Vesting period                       4 years      
Future grants under the Plan (in Dollars)               $ 1,609,011       $ 1,609,011      
Total warrants shares (in Shares) 10,000     500,000 10,000 10,000                  
Exercise price per share (in Dollars per share) $ 34.77     $ 31.17 $ 34.35 $ 30.9 $ 35.15                
Term year 5 years     7 years 5 years 5 years 10 years                
Vasting period 1 year       1 year 1 year 4 years                
Aggregate fair value of options (in Dollars) $ 212,219     $ 10,241,599 $ 211,653 $ 190,401                  
Discount rate 0.43%     0.48% 0.43% 0.47%                  
Expected life term 3 years     3 years 6 months 3 years 3 years                  
Expected volatility rate 99.00%     101.00% 100.00% 100.00%                  
Expected dividends rate 0.00%     0.00% 0.00% 0.00%                  
performance metrics for options (in Shares)                       468,000      
Incurred expense (in Dollars)               $ 2,268,562       $ 2,268,562      
Awarded Options to an employee (in Shares)             25,000                
Unrecognized stock-based compensation expenses                       67 years 7 months 6 days      
Weighted average remaining service period               2 years 9 months 3 days       2 years 9 months 3 days      
Unrecognized compensation expense (in Dollars)                       $ 12,500,000      
Aggregate intrinsic value of warrants vested (in Dollars)               $ 40,000,000       40,000,000     $ 61,000,000
Aggregate intrinsic value (in Dollars)               $ 40,100,000       $ 40,100,000     $ 61,200,000
Employees and Directors [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Total warrants shares (in Shares)   1,490,000                          
Exercise price per share (in Dollars per share)   $ 33.43                          
Term year   10 years                          
Vasting period   4 years                          
Aggregate fair value of options (in Dollars)   $ 39,700,000         $ 701,000                
Discount rate   0.59%         0.75%                
Expected life term   6 years 3 months         6 years 3 months                
Expected volatility rate   101.00%         101.00%                
Expected dividends rate   0.00%         0.00%                
Jefferies LLC [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Issued of common stock (in Shares)     651,674                        
Aggregate of offering price (in Dollars)     $ 75,000,000                        
Net cash proceeds (in Dollars)     23,416,036                        
Common Stock [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Issued of common stock (in Shares)               356,385       356,385      
Cash exercises of warrants for proceeds (in Dollars)                       $ 2,116,969      
Exercised common shares issued (in Shares)                       160,556      
Exercise of options for proceeds (in Dollars)               $ 12 $ 25 $ 113 $ 3 $ 569,427      
Common Stock [Member] | Jefferies LLC [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Net cash proceeds (in Dollars)     $ 19,816,597                        
Consultants [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Total warrants shares (in Shares)   400,000                          
Exercise price per share (in Dollars per share)   $ 33.43                          
Term year   10 years                          
Vasting period   4 years                          
Aggregate fair value of options (in Dollars)   $ 10,600,000                          
Discount rate   0.59%                          
Expected life term   6 years 3 months                          
Expected volatility rate   101.00%                          
Expected dividends rate   0.00%                          
Performance metrics relating (in Shares)                         180,000    
Warrant expense (in Dollars)                         $ 872,524